Generic Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded ones, hence they are being preferred on a large scale during the recent years.

MARKET DYNAMICS

The generic drugs market is anticipated to grow in the forecast period since they are available at a cost effective price and also offer similar results as their branded counterparts. In addition, the benefits of generic drugs over the macroscopic medicines is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Generic Drugs Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of generic drugs market with detailed market segmentation by product type, application, distribution channel and geography. The global generic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading generic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global generic drugs market is segmented on the basis of product type, application and distribution channel. Based on product type, the market is segmented as biosimilars, super generic and simple generic. The generic drugs market, based on application is segmented into, anti-infective drugs, anti-arthritis drugs, anti-cancer drugs, central nervous system drugs, cardiovascular drugs, respiratory drugs and other applications. On the basis of distribution channel, the global generic drugs market is segmented into, hospitals, pharmacies, private clinics and other distribution channels.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global generic drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The generic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting generic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the generic drugs market in these regions.

MARKET PLAYERS

The reports cover key developments in the generic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from generic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for generic drugs market in the global market. Below mentioned is the list of few companies engaged in the generic drugs market.

The report also includes the profiles of key generic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Dr. Reddy's Laboratories Ltd.
• Novartis Pharmaceuticals Corporation
• Apotex Inc.
• Pfizer Inc.
• Endo Pharmaceuticals Inc.
• Fresenius Kabi AG
• Lupin Pharmaceuticals, Inc.
• Cipla Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Generic Drugs Report Scope